CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 12 enrolled
Drug / intervention
Continuous glucose monitoring (Dexcom G6)device
Likely dose
Dexcom G6 continuous glucose monitoring device worn for up to 10 daysAI-extracted
Key inclusion· 4
  • Age 75 years or older
  • Diabetes diagnosis
  • Currently treated with sulfonylureas and/or insulin
  • Presenting to hospital with a fall and/or symptoms suggestive of unrecognised hypoglycaemia (such as dizziness, feeling muddled)
Key exclusion· 5
  • Treatment with metformin alone
  • Lack of capacity to consent
  • Not willing to participate
  • Terminal illness with less than one-year life expectancy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05470842
NCT05470842N/ACompleted

How Common is Hypoglycaemia in Older People With Diabetes Who Have Falls, Dizziness or Other Symptoms Suggestive of Hypoglycaemia? A Continuous Glucose Monitoring Study

University of East Anglia·interventional·Posted Jul 22, 2022·Updated Sep 23, 2024

In Brief

A clinical study evaluating Continuous glucose monitoring (Dexcom G6) for Diabetes and Hypoglycaemia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

The purpose of this study is to use 24 hour continuous glucose monitoring in older patients with diabetes who present with symptoms of falls, or dizziness, or confusion, that may indicate hypoglycaemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 22, 2022
Enrollment StartJun 6, 2023
Primary CompletionSep 22, 2023
Study CompletionOct 31, 2023
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 3.9 years ago

Interventions

Continuous glucose monitoring (Dexcom G6)device

All participants will be issued with the Dexcom G6 device. The trial team will buy the readers or smartphones and sensors and provide the participants with all the necessary equipment. Participants will be shown how to wear the Dexcom G6 device, which they will be asked to wear for up to 10 days (=the lifespan of one sensor). There will be no change in the standard care of the participants' diabetes management, during the study period.